Patients with CRF (chronic renal failure) are at increased risk of cardiovascular diseases, and 60 % of cardiovascular mortality in CRF is attributed to sudden death. Various abnormalities in myocardial repolarization are associated with the risk of ventricular arrhythmia. The aim of this study was to evaluate an index of temporal myocardial repolarization lability, the temporal QTVI (QT variability index), in patients with CRF. ECGs were recorded in 153 patients with CRF on haemodialysis (n = 67), continuous ambulatory peritoneal dialysis (n = 43) or conservative treatment (n = 43) during 30 min of rest. QTVI was calculated as the logarithm of the ratio between the variances of the normalized QT and RR intervals. Age-matched healthy subjects (n = 39) were examined for comparison. QTVI was increased by 47 % in CRF patients compared with healthy subjects (− 0.82 + − 0.56 compared with − 1.54 + − 0.27 respectively; P < 0.01). QTVI did not differ among patients on dialysis or conservative treatment, whereas QTVI was elevated further in patients with diabetes compared with non-diabetic CRF patients (− 0.56 + − 0.54 compared with − 0.94 + − 0.52 respectively; P < 0.01). In a multiple linear regression analysis, diabetes and a history of coronary artery disease were the only independent predictors of QTVI in the CRF population. The present study demonstrates that elevated QTVI in patients with CRF is associated with diabetes and coronary disease. The present findings are important given that repolarization instability may predispose to ventricular arrhythmia and sudden death, events that occur frequently in CRF patients.
INTRODUCTION
Cardiovascular disease is the largest single cause of death in patients with CRF (chronic renal failure), accounting for approx. 50 % of total mortality [1, 2] . Patients with CRF are at increased risk for ventricular arrhythmia and sudden death, and this may cause up to 60 % of cardiac deaths in dialysis patients [3] . In particular, CRF patients with diabetes appear at high risk, with a reported incidence of cardiac arrest of approx. 20 % in the first 2 years after the initiation of dialysis treatment [4] . There are several possible mechanisms for the increased risk of sudden death in CRF patients. First, the prevalence of left ventricular hypertrophy, which has been associated with sudden death, has been reported to be as high as 75 % in CRF patients [1] . In addition, high prevalence of coronary artery disease, myocardial scarring and remodelling, together with electrolyte shifts and elevated sympathetic nervous activity in haemodialysis patients, are other mechanisms explaining the increased risk of sudden death [1, 5] . Moreover, modulation of cardiac parasympathetic nervous activity that protects against ventricular arrhythmia is impaired in CRF patients [6, 7] .
The QT interval of the ECG is a measurement of the duration of ventricular depolarization and repolarization. Disturbed repolarization in terms of increased difference in the QT interval corrected for heart rate between different ECG leads, QT dispersion, has been associated with increased risk for ventricular arrhythmia and mortality both in patients with congestive heart failure and in the general population [8] . There are two studies reporting elevated QT dispersion in CRF patients on haemodialysis treatment compared with healthy subjects [9, 10] . Elevated QT dispersion may reflect spatial inhomogeneity in myocardial repolarization, but the validity and reliability of the method has been questioned [11] . By using a computer algorithm, the temporal QTVI (QT variability index) can be calculated. QTVI provides an estimation of the temporal variability in the myocardial repolarization process [12, 13] . This method of assessing myocardial repolarization is interesting given that it is less operator-dependent compared with the measurement of QT dispersion. Although there are few prospective studies regarding the prognostic value of QTVI, published data indicate that an elevated QTVI is associated with an increased risk for ventricular arrhythmia [12] . However, there is no information regarding QTVI in CRF patients. Thus the aim of the present study was to assess QTVI in a large group of patients with CRF on haemodialysis, CAPD (continuous ambulatory peritoneal dialysis) or conservative treatment in comparison with age-matched healthy controls. Given that CRF patients with concomitant diabetes have an adverse prognosis [14] , subgroup analysis of QTVI in CRF patients without and with diabetes was a secondary aim of the study.
MATERIALS AND METHODS

Ethical approval
The local Ethical Committee at Sahlgrenska University Hospital approved the study, and all subjects gave their informed consent to participate in the study.
CRF patients
Patients with CRF (n = 153) were recruited from eight hospitals in the western region of Sweden. Inclusion (range, 7-34 ml · min −1 · 1.73 m −2 ) measured by Cr-EDTA or Iohexol clearance. Exclusion criteria were atrial fibrillation, permanent pacemaker, myocardial infarction or stroke within the preceding 3 months and > 5 % extra systoles or an inadequate ECG signal for T-wave detection. Clinical information was provided by responsible nephrologists. Clinical variables, medication and laboratory data are given in Table 1 . Of the CRF patients, 91 % were hypertensive or had antihypertensive treatment. The majority (70 %) of patients who were on β-blocker treatment were taking metoprolol and the average dose was 85 mg (range, 25-300 mg). A history of coronary artery disease was present in 20 % of the CRF patients, including previous myocardial infarction, coronary artery bypass operation, percutaneous coronary angioplasty or angina pectoris. Ten CRF patients had a previous history of congestive heart failure. Seven of those were in NYHA (New York Heart Association) function class II and three in function class III. A normal ECG was found in 65 % of the patients, whereas 17 % fulfilled criteria of left ventricular hypertrophy (R wave in ECG lead V5 of 26 mm or R wave in lead V5 + S wave in lead V1
35 mm or ST-T changes in leads I, aVL or V4-6), 10 % had bundle branch blocks and 9 % had pathological Q waves suggesting previous myocardial infarctions. Almost one-third (32 %) of the CRF patient had diabetes (n = 49), with an average disease duration of 26 years (range, 2 months to 50 years). The aetiology of renal failure was diabetes mellitus (29 %), glomerulonephritis (25 %), hypertension (9 %), polycystic kidney disease (6 %) and miscellaneous or unknown causes (31 %).
Patients on haemodialysis treatment (n = 67) were treated in hospital three times a week. The fractional urea clearance was 1.6 + − 0.9 (Kt/V urea ; value is mean + − S.D.). Likewise, patients on CAPD (n = 43) or conservative treatment (n = 43) received standard treatment regimens. The average duration of haemodialysis and CAPD treatments was 2.0 years (range, 1 month to 12 years).
Healthy subjects
Thirty-nine age-and BMI (body mass index; weight/ height 2 )-matched healthy controls were recruited from the staff at Sahlgrenska University Hospital and by advertisement in a local newspaper. All healthy subjects were non-smokers, had no significant past medical history and were not taking any regular medication. They were normotensive, had normal BMI and a normal ECG.
Data acquisition and calculations
All subjects refrained from caffeine-containing beverages for at least 12 h before the investigations. Patients on haemodialysis treatment were investigated on the day when they did not receive dialysis treatment. On arrival at the laboratory, subjects rested supine in a quiet room with comfortable temperature for about 10 min. After the resting period, a surface ECG (lead II) was acquired for 30 min in CRF patients and 20 min in healthy subjects.
Registrations were recorded at a sampling frequency of 1000 Hz and stored on a computer. The recordings were inspected off-line for removal of artefactual segments and sequences containing non-sinus beats. Ectopic beats were corrected by interpolation.
A stationary period of 5 min with less than 5 % atrial/ ventricular ectopic beats was chosen for the temporal QT interval variability analysis using a computer algorithm [13] . The examiner defined a template QT interval for one beat from the beginning of the QRS complex to the end of T wave, including all deflections that might relate to repolarization including possible U waves. Thus the length of the QT interval was often longer compared with the standard measurement of the QT interval. The algorithm found the QT intervals of all other beats by determining the stretch or compression in time of each beat to best match the ST segment and the T wave of the template beat, while the QRS complex was ignored. RR interval mean (RRm) and variance (RRv) and QT interval mean (QTm) and variance (QTv) were derived from the respective time series. QTVI, which represents the log ratio between normalized QT and RR interval variability, was calculated according to the equation:
Thus a difference of 1 between two individuals implies a 10 times difference in temporal QT variability normalized to the QT interval, RR variance (heart rate variability calculated in the time domain) and the RR interval. The squared coherence function, which is a measure of the degree of linear interaction between RR and QT interval fluctuations, was calculated from power spectra of the RR and QT interval time series, and the cross spectrum between these two series derived by Fast Fourier Transform (Welch algorithm, five blocks, 50 % overlap, Hanning window). The mean squared coherence was obtained by averaging the coherence function over the frequency band from 0 and 0.45 Hz. The coherence provides a measure of the degree of linear interaction between the RR and QT interval fluctuations as a function of the frequency of those fluctuations [13] . The ECG and blood pressure recordings were performed by three different technicians and the analyses of the recordings were carried out later by two investigators that were blinded regarding the clinical data of the subjects.
We have recently performed measurements of reproducibility for QTVI [14a] . In our hands, the intraexaminer coefficients of variation of the QTVI measurements were 7 % in both healthy subjects and CRF patients, whereas the inter-examiner coefficients of variation were 5 % in healthy subjects and 11 % in CRF patients. When the subjects were examined on two different occasions, on average 1 week apart, the withinsubject coefficients of variation for QTVI were 18 % and 40 % in healthy subjects and CRF patients respectively.
Statistics
Numerical distributions are presented by their means + − S.D. Student's t test for unpaired comparisons was used for continuous data with a normal distribution. QTVI values showed a non-normal distribution and, hence, the Mann-Whitney U test for unpaired comparisons was used. The χ 2 test was used for binomial data. The relationship between two variables was assessed from bivariate scatter plots, and calculation of the rank correlation coefficient was performed according to Spearman. A multiple forward stepwise linear regression analysis was performed with QTVI as the dependent variable. All variables with significant univariate association to QTVI were added to the model. Statistical significance was defined as P < 0.05.
RESULTS
QTVI, QT or RR variance did not differ among subgroups of patients receiving haemodialysis, CAPD or conservative treatment. There was no difference in QTVI between CRF patients on conservative treatment and those treated by dialysis (− 0.89 + − 0.54 compared with − 0.79 + − 0.56; P value was not significant). Hence all CRF patients were pooled into one group and compared with healthy subjects. There was no difference regarding age, gender and BMI between patients with CRF and healthy subjects ( Table 2 ). The heart rate and systolic and diastolic blood pressures were elevated in CRF patients compared with healthy controls by 13 %, 19 % and 5 % respectively (P < 0.05 for all; Table 2 ). QTVI and the QT variance were increased by 47 % and 146 % respectively (P < 0.01), whereas the RR variance was reduced by 69 % (P < 0.01; Table 3 ) in CRF patients compared with healthy subjects. In Figure 1 the individual QTVI values for both groups are displayed. CRF patients on haemodialysis, CAPD or conservative treatment all showed elevated QTVI compared with healthy subjects (P < 0.01 for all). Mean QT intervals were similar in the two study groups, whereas the mean squared coherence between QT and RR time series was reduced by 18 % in the patient group compared with healthy subjects (P < 0.01; Table 3 ). In a subgroup analysis, QTVI was higher in CRF patients with diabetes compared with patients without diabetes, whereas the variance of the RR intervals (heart Figure 1 Scatter plot showing the individual QTVI values for CRF patients and healthy subjects (HS) * * P < 01 compared with healthy subjects.
rate variability) was reduced in CRF patients with diabetes (P < 0.01; Table 3 ). Furthermore, patients with overt coronary artery disease showed elevated QTVI and QT variance compared with the other CRF patients (QTVI, − 0.49 + − 0.67 compared with − 0.89 + − 0.51 respectively; QT variance, 65 + − 112 compared with 19 + − 21 ms 2 respectively; P < 0.01 for both), whereas the variance of the RR intervals was reduced in the former group (489 + − 542 compared with 917 + − 1099 ms 2 ; P < 0.05). When including only CRF patients without a history of diabetes, coronary artery disease or congestive heart failure in the analysis, QTVI was still elevated compared with healthy subjects (− 0.98 + − 0.51 compared with − 1.54 + − 0.27; P < 0.01). Patients with an abnormal ECG (left ventricular hypertrophy, bundle branch block or pathological Q waves) had elevated QTVI compared with CRF patients with normal ECGs (− 0.64 + − 0.63 compared with − 0.90 + − 0.51 respectively; P < 0.05). Patients receiving treatment with a β-blocker showed similar QTVI values, but lower heart rate than patients without β-blocker treatment (68 + − 1 compared with 75 + − 1 beats/ min respectively; P < 0.001). There were no differences in QTVI between patients on or off treatment with an ACE (angiotensin-converting enzyme) inhibitor, angiotensin II receptor blocker, calcium channel blocker or diuretics.
The relationship between QTVI and the following factors was analysed in the CRF population using simple regression: age, systolic blood pressure, BMI, serum sodium, potassium and calcium and plasma albumin as continuous variables and gender, smoking habit, coronary artery disease, peripheral arterial disease, congestive heart failure, chronic obstructive disease, stroke, diabetes mellitus, treatment with a β-blocker, ACE inhibitor/angiotensin receptor blocker and abnormal/normal ECG as binary variables having values 0 or 1 for each individual. Using univariate regression analysis, age, overt coronary artery disease (angina pectoris, previous coronary artery bypass surgery, coronary angioplasty or myocardial infarction), peripheral arterial disease, congestive heart failure, abnormal/normal ECG and systolic blood pressure were significantly associated with QTVI and were thus tested in the multivariate model. A forward stepwise multiple regression analysis was performed. Diabetes mellitus (regression coefficient B = 0.49, standard error of b = 0.09; P < 0.001) and overt coronary artery disease (B = 0.46, standard error of b = 0.10; P < 0.001) were the only associated predictors of QTVI in this model (multiple r = 0.50, r 2 = 0.25; P < 0.001; intercept − 1.17).
DISCUSSION
The present study demonstrates elevated QTVI in CRF patients on haemodialysis, CAPD or conservative treatment. This finding is important given that myocardial repolarization instability, which QTVI reflects, may predispose to ventricular arrhythmia and sudden death, events that occur frequently in CRF patients. Patients with diabetes or coronary artery disease in addition to renal failure appear to be at particularly high risk: these individuals have QTVI values comparable with those reported previously in ischaemic or dilated cardiomyopathy [13] . To our knowledge, the present study is the first to investigate beat-to-beat QT variability in CRF patients. The augmentation of QTVI (the quotient) was the result of both reduced RR interval variance (the denominator) and increased QT interval variance (the numerator). Reduced heart rate variability corroborates previous reports of reduced autonomic control of heart rate in CRF patients [6, 15] . The present data expands previous reports of elevated QT dispersion in CRF patients on dialysis treatment to show that QTVI, an index of temporal instability of myocardial repolarization, is also increased [9, 10] . Moreover, an elevated QTVI was also seen in CRF patients on conservative treatment.
It is unclear whether QT dispersion and QTVI provide information about myocardial repolarization that is redundant or complementary. Whereas Berger et al. [13] reported no correlation between the two measurements in patients with dilated cardiomyopathy, Piccirillo et al. [16] reported a positive relationship between the two measurements in a mixed population of normotensives, patients with primary hypertension and hypertrophic cardiomyopathy. Furthermore, in patients with ischaemic or dilated cardiomyopathy, a graded relationship between NYHA function class and QTVI has been reported, whereas no such relationship could be demonstrated for QT dispersion [13] . Although there have been few reports regarding the prognostic value of QTVI, Atiga et al. [12] reported that QTVI predicted the subsequent risk of sudden death or ventricular arrhythmia in patients who underwent electrophysiological investigations, whereas QT dispersion did not. Future prospective studies are needed to establish whether QTVI or QT dispersion is the most valuable variable in predicting the risk for cardiovascular morbidity.
The mechanisms behind elevated temporal QT variability have yet to be elucidated. Several factors are involved in the regulation of myocardial repolarization and their interaction is complex and incompletely understood. There is evidence that temporal repolarization instability arises at the level of the single cell, and explanations such as altered repolarization currents, abnormal intracellular ionic cycling and disease-induced changes in intercellular coupling have been proposed [17] . Reduced RR-QT interval coherence has been reported previously in patients with congestive heart failure, indicating a loss of the normal coupling between the RR and QT intervals [13] . The RR-QT interval coherence was reduced in CRF patients. However, the slightly reduced RR-QT interval coherence among CRF patients could only have partly contributed to the markedly elevated QTVI observed.
Structural changes of the left ventricle, such as dilation and scarring in ischaemic or dilated cardiomyopathy or left ventricular hypertrophy in hypertension, are associated with elevated QTVI [12, 16] . Hence co-existing cardiovascular diseases in CRF patients, including diabetes, hypertension (more than 90 % prevalence in the present study), coronary artery disease and heart failure, could have induced structural changes within the myocardium that may explain some of the observed increase in QTVI. This is supported by the multiple regression analysis where manifest coronary artery disease, together with diabetes mellitus, were independent predictors of QTVI. Coronary disease is often silent and ischaemic heart disease with fibrosis and scarring is probably one of several mechanisms causing the elevated QTVI in CRF patients [18, 19] . Furthermore, diabetic cardiomyopathy and/or neuropathy of the cardiac autonomic nervous system could also have contributed to the elevated QTVI observed in the diabetic subgroup [20, 21] .
Study limitations
Antihypertensive drug therapy, including β-blockers, ACE inhibitors, angiotensin II receptor antagonists and calcium antagonists, could have interfered with the QTVI measurements in the present study. An improvement of QTVI has been demonstrated in congestive heart failure patients after 1 year of treatment with a β-blocker [22] . However, in the present study, CRF patients who were on β-blocker treatment did not differ regarding QTVI from CRF patients without treatment. Neither did we find any drug effects on QTVI in patients using other classes of antihypertensive drugs. In spite of this, a drug influence on QTVI cannot be ruled out, although a major effect seems unlikely.
Previous studies have suggested a positive relationship between left ventricular hypertrophy and QTVI and, hence, another limitation of the present study is that echocardiography was not performed [16] . According to our experience, QTVI measurements show a fairly good reproducibility when the analysis is performed by several investigators, whereas the within-subject variability of QTVI is much higher (between 18 and 40 %; [14a] ) when the subjects are examined on different occasions. Thus small QTVI differences should be interpreted with caution.
Whereas the present study establishes the presence of elevated QTVI in a large population of CRF patients on either conservative or dialysis treatment, future studies are needed to explore the mechanisms involved and to investigate whether an elevated QTVI could predict the future risk of cardiovascular events in these patients.
